Bo Zhang

11PUBLICATIONS
9CO-AUTHORS
Gene and molecular therapyGene expression (incl. microarray and other genome-wide approaches)Epigenetics (incl. genome methylation and epigenomics)PharmacogenomicsEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 17, 2025
Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes.

Lixin Guo, Bo Zhang, Xia Xue

|Oct 04, 2024
Assessing and predicting type 2 diabetes risk with triglyceride glucose-body mass index in the Chinese nondiabetic population-Data from long-term follow-up of Da Qing IGT and Diabetes Study.

Haixu Wang, Siyao He, Jinping Wang

|Aug 19, 2024
Influence of impaired glucose tolerance alone and combined with metabolic syndrome on long-term risk of cardiovascular events and mortality.

Fei Chen, Yifan He, Jinping Wang

|Apr 07, 2024
Efficacy and safety of bexagliflozin compared with dapagliflozin as an adjunct to metformin in Chinese patients with type 2 diabetes mellitus: A 24-week, randomized, double-blind, active-controlled, phase 3 trial.

Lingding Xie, Jie Han, Zhifeng Cheng

|Mar 15, 2024
Efficacy of 1-hour postload plasma glucose as a suitable measurement in predicting type 2 diabetes and diabetes-related complications: A post hoc analysis of the 30-year follow-up of the Da Qing IGT and Diabetes Study.

Minying Peng, Siyao He, Jinping Wang

|Jan 03, 2024
Influence of a diet and/or exercise intervention on long-term mortality and vascular complications in people with impaired glucose tolerance: Da Qing Diabetes Prevention Outcome study.

Liping Yu, Jinping Wang, Qiuhong Gong

Pageof 2

Frequent Collaborators

5 joint publications

Guangwei Li

4 joint publications

Qiuhong Gong

3 joint publications

Fei Chen

3 joint publications

Xin Qian